Pesando D, Pesci-Bardon C, Huitorel P, Girard J P
Laboratoire de Physiologie et Toxicologie Environnementales, Université de Nice-Sophia Antipolis, Faculté des Sciences, Nice, France.
Eur J Cell Biol. 1999 Dec;78(12):903-10. doi: 10.1016/s0171-9335(99)80092-2.
In a previous study, we demonstrated that caulerpenyne (Cyn), a natural sesquiterpene having an antiproliferative potency, blocked the mitotic cycle of sea urchin embryos at metaphase and inhibited the phosphorylation of several proteins, but did not affect histone H1 kinase activation (Pesando et al, 1998, Eur. J. Cell Biol. 77, 19-26). Here, we show that concentrations of Cyn that blocked the first division of the sea urchin Paracentrotus lividus embryos in a metaphase-like stage (45 microM) also inhibited the stimulation of mitogen-activated protein kinase (MAPK) activity in vivo as measured in treated egg extracts using myelin basic protein (MBP) as a substrate (MBPK). However, Cyn had no effect on MBP phosphorylation when added in vitro to an untreated egg extract taken at the time of metaphase, suggesting that Cyn acts on an upstream activation process. PD 98059 (40 microM), a previously characterized specific synthetic inhibitor of MAPK/extracellular signal-regulated kinase-1 (MEK1), also blocked sea urchin eggs at metaphase in a way very similar to Cyn. Both molecules induced similar inhibitory effects on MBP kinase activation in vivo, but had no direct effect on MBP kinase activity in vitro, whereas they did not affect H1 kinase activation neither in vivo nor in vitro. As a comparison, butyrolactone 1 (100 microM), a known inhibitor of H1 kinase activity, did inhibit H1 kinase of sea urchin eggs in vivo and in vitro, and blocked the sea urchin embryo mitotic cycle much before metaphase. Immunoblots of mitotic extracts, treated with anti-active MAP-kinase antibody, showed that both Cyn and PD 98059 reduced the phosphorylation of p42 MAP kinase (Erk2) in vivo. Our overall results suggest that Cyn blocks the sea urchin embryo mitotic cycle at metaphase by inhibiting an upstream phosphorylation event in the MBPK activation pathway. They also show that H1 kinase and MBPK activation can be dissociated from each other in this model system.
在先前的一项研究中,我们证明了海栖弗林(Cyn),一种具有抗增殖能力的天然倍半萜,可使海胆胚胎的有丝分裂周期在中期受阻,并抑制多种蛋白质的磷酸化,但不影响组蛋白H1激酶的激活(佩桑多等人,1998年,《欧洲细胞生物学杂志》77卷,第19 - 26页)。在此,我们表明,能使海胆Paracentrotus lividus胚胎的第一次分裂在类似中期的阶段受阻的海栖弗林浓度(45微摩尔),在体内也抑制了有丝分裂原激活的蛋白激酶(MAPK)活性的刺激,这是通过使用髓鞘碱性蛋白(MBP)作为底物(MBPK)在处理过的卵提取物中测量得到的。然而,当在中期时将海栖弗林体外添加到未处理的卵提取物中时,它对MBP磷酸化没有影响,这表明海栖弗林作用于上游激活过程。PD 98059(40微摩尔),一种先前已表征的MAPK/细胞外信号调节激酶-1(MEK1)的特异性合成抑制剂,也以与海栖弗林非常相似的方式使海胆卵在中期受阻。这两种分子在体内对MBP激酶激活诱导了相似的抑制作用,但在体外对MBP激酶活性没有直接影响,而且它们在体内和体外均不影响H1激酶的激活。作为比较,丁内酯1(100微摩尔),一种已知的H1激酶活性抑制剂,在体内和体外确实抑制了海胆卵的H1激酶,并在中期之前很久就阻断了海胆胚胎的有丝分裂周期。用抗活性MAP激酶抗体处理的有丝分裂提取物的免疫印迹显示,海栖弗林和PD 98059在体内均降低了p42 MAP激酶(Erk2)的磷酸化。我们的总体结果表明,海栖弗林通过抑制MBPK激活途径中的上游磷酸化事件,在中期阻断海胆胚胎的有丝分裂周期。它们还表明,在这个模型系统中,H1激酶和MBPK的激活可以相互分离。